Human amniotic fluid-derived and dental pulp-derived stem cells seeded into collagen scaffold repair critical-size bone defects promoting vascularization

Stem Cell Research and Therapy

Volumn 4, Issue 3, 2013, Pages

  Maraldi, Tullia ^a   Riccio, Massimo ^a   Pisciotta, Alessandra ^a   Zavatti, Manuela ^a   Carnevale, Gianluca ^a   Beretti, Francesca ^a   La Sala, Giovanni B ^b   Motta, Antonella ^c   De Pol, Anto ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Arcispedale Santa Maria Nuova ^*  (Italy)

^c UNIVERSITY OF TRENTO   (Italy)

Author keywords

Bone; Collagen scaffold; Regenerative medicine; Stem cells; Vascularization

Indexed keywords

COLLAGEN; MITOCHONDRIAL PROTEIN; TISSUE SCAFFOLD;

AMNIOTIC FLUID CELL; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CELL; BONE IMPLANT; BONE REGENERATION; BONE TISSUE; CELL LINEAGE; CONTROLLED STUDY; DISEASE SEVERITY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MALE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; SKULL DEFECT; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TOOTH PULP; VASCULARIZATION; AMNION FLUID; ANIMAL; BONE; BONE DEVELOPMENT; BONE DISEASES; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; RADIOGRAPHY; REGENERATIVE MEDICINE; STEM CELL; TISSUE SCAFFOLD; XENOGRAFT;

ANIMALIA; RATTUS;

AMNIOTIC FLUID; ANIMALS; BONE AND BONES; BONE DISEASES; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN; DENTAL PULP; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; RATS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE SCAFFOLDS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84877889085     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt203     Document Type: Article

References (43)

1. Bone graft substitutes. Laurencin CT, Khan Y, El-Amin SF, Expert Rev Med Devices 2006 1 49 57
2. Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. De Long WG, Einhorn TA Jr, Koval K, McKee M, Smith W, Sanders R, Watson T, J Bone Joint Surg Am 2007 89 649 658 10.2106/JBJS.F.00465 17332116 (Pubitemid 46365369)
3. Bone-graft substitutes in orthopaedic surgery. Jahangir AANRM, Mehta S, Sharan A, Washington Health Policy Fellows, AAOS Now 2008 2 [ http://www6.aaos.org/news/PDFopen/PDFopen.cfm?page-url=http://www.aaos.org/news/ aaosnow/jan08/reimbursement2.asp ]
4. The use of allograft bone in spine surgery: is it safe? Mroz TE, Joyce MJ, Lieberman IH, Steinmetz MP, Benzel EC, Wang JC, Spine J 2009 9 303 308 10.1016/j.spinee.2008.06.452 18805063
5. Cell-scaffold transplant of hydrogel seeded with rat bone marrow progenitors for bone regeneration. Ben-David D, Kizhner TA, Kohler T, Müller R, Livne E, Srouji S, J Craniomaxillofac Surg 2011 39 364 371 10.1016/j.jcms.2010.09.001 20947366
6. The synergistic effects of 3-D porous silk fibroin matrix scaffold properties and hydrodynamic environment in cartilage tissue regeneration. Wang Y, Bella E, Lee CSD, Migliaresi C, Pelcaster L, Schwartz Z, Boyan BD, Motta A, Biomaterials 2010 31 4672 4681 10.1016/j.biomaterials.2010.02.006 20303584
7. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Kim J, Kim IS, Cho TH, Lee KB, Hwang SJ, Tae G, Tae G, Noh I, Lee SH, Park Y, Sun K, Biomaterials 2007 28 1830 1837 10.1016/j.biomaterials.2006.11.050 17208295 (Pubitemid 46123539)
8. Design of an artificial skin. II. Control of chemical composition. Yannas IV, Burke JF, Gordon PL, Huang C, Rubenstein RH, J Biomed Mater Res 1980 14 107 132 10.1002/jbm.820140203 7358747
9. Design of an artificial skin. Part III. Control of pore structure. Dagalakis N, Flink J, Stasikelis P, Burke JF, Yannas IV, J Biomed Mater Res 1980 14 511 528 10.1002/jbm.820140417 7400201 (Pubitemid 10086173)
10. Tools for tissue engineering of mineralized oral structures. Dard M, Sewing A, Meyer J, Verrier S, Roessler S, Scharnweber D, Clin Oral Investig 2000 4 126 129 10.1007/s007840050128 11218500
11. Silk based biomaterials to heal critical sized femur defects. Meinel L, Betz O, Fajardo R, Hofmann S, Nazarian A, Cory E, Hilbe M, McCool J, Langer R, Vunjak-Novakovic G, Merkle HP, Rechenberg B, Kaplan DL, Kirker-Head C, Bone 2006 39 922 931 10.1016/j.bone.2006.04.019 16757219 (Pubitemid 44311718)
12. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. Young RG, Butler DL, Weber W, Caplan AI, Gordon SL, Fink DJ, J Orthop Res 1998 16 406 413 10.1002/jor.1100160403 9747780 (Pubitemid 28427689)
13. Autologous mesenchymal stem cell-mediated repair of tendon. Awad HA, Butler DL, Boivin GP, Smith FN, Malaviya P, Huibregtse B, Caplan AI, Tissue Eng 1999 5 267 277 10.1089/ten.1999.5.267 10434073 (Pubitemid 29296109)
14. The effects of glycosaminoglycan content on the compressive modulus of cartilage engineered in type II collagen scaffolds. Pfeiffer E, Vickers SM, Frank E, Grodzinsky AJ, Spector M, Osteoarthr Cartil 2008 16 1237 1244 10.1016/j.joca.2008.02.014 18406634
15. Multilineage potential of adult human mesenchymal stem cells. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR, Science 1999 284 143 147 10.1126/science.284.5411.143 10102814 (Pubitemid 29282067)
16. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Kadiyala S, Young RG, Thiede MA, Bruder SP, Cell Transplant 1997 6 125 134 10.1016/S0963-6897(96)00279-5 9142444 (Pubitemid 27188295)
17. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP, J Cell Biochem 1997 64 295 312 10.1002/(SICI)1097-4644(199702)64:2<295:: AID-JCB12>3.0.CO;2-I 9027589 (Pubitemid 27065443)
18. Fibroin scaffold repairs critical-size bone defects in vivo supported by human amniotic fluid and dental pulp stem cells. Riccio M, Maraldi T, Pisciotta A, La Sala GB, Ferrari A, Bruzzesi G, Motta A, Migliaresi C, De Pol A, Tissue Eng Part A 2012 18 1006 1013 10.1089/ten.tea.2011.0542 22166080
19. Human amniotic fluid stem cells seeded in fibroin scaffold produce in vivo mineralized matrix. Maraldi T, Riccio M, Resca E, Pisciotta A, La Sala GB, Ferrari A, Bruzzesi G, Motta A, Migliaresi C, Marzona L, De Pol A, Tissue Eng Part A 2011 17 2833 2843 10.1089/ten.tea.2011.0062 21864161
20. Biomaterials in orthopaedics. Navarro M, Michiardi A, Castano OJ, Planell A, J R Soc Interface 2008 5 1137 1158 10.1098/rsif.2008.0151 18667387
21. Engineering vascularized tissue. Jain RK, Au P, Tam J, Duda DG, Fukumura D, Nat Biotechnol 2005 23 821 823 10.1038/nbt0705-821 16003365 (Pubitemid 43093121)
22. Porosity of 3D biomaterial scaffolds and osteogenesis. Karageorgiou V, Kaplan D, Biomaterials 2005 26 5474 5491 10.1016/j.biomaterials.2005.02.002 15860204 (Pubitemid 40592136)
23. The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (varepsilon-caprolactone)/collagen fibers and hyaluronic acid hydrogel. Ekaputra AK, Prestwich GD, Cool SM, Hutmacher DW, Biomaterials 2011 32 8108 8117 10.1016/j.biomaterials.2011.07.022 21807407
24. Controlling the porosity of fibrous scaffolds by modulating the fiber diameter and packing density. Soliman S, Sant S, Nichol JW, Khabiry M, Traversa E, Khademhosseini A, J Biomed Mater Res A 2011 96 566 574 21254388
25. Human serum promotes osteogenic differentiation of human dental pulp stem cells in vitro and in vivo. Pisciotta A, Riccio M, Carnevale G, Beretti F, Gibellini L, Maraldi T, Cavallini GM, Ferrari A, Bruzzesi G, De Pol A, PLoS One 2012 7 50542 10.1371/journal.pone.0050542 23209773
26. Isolation of amniotic stem cell lines with potential for therapy. De Coppi P, Bartsch G, Siddiqui MM, Xu T, Santos CC, Perin L, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A, Nat Biotechnol 2007 25 100 106 10.1038/nbt1274 17206138 (Pubitemid 46087908)
27. Human dental pulp stem cells produce mineralized matrix in 2D and 3D cultures. Riccio M, Resca E, Maraldi T, Pisciotta A, Ferrari A, Bruzzesi G, De Pol A, Eur J Histochem 2010 10 46
28. MATER protein as substrate of PKCepsilon in human cumulus cells. Maraldi T, Riccio M, Sena P, Marzona L, Nicoli A, La Marca A, Marmiroli S, Bertacchini J, La Sala G, De Pol A, Mol Hum Reprod 2009 15 499 506 10.1093/molehr/gap048 19542546
29. Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro. Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, Lanzoni G, Cantoni S, Cavallini C, Bianchi F, Tazzari PL, Pasquinelli G, Foroni L, Ventura C, Grossi A, Bagnara GP, BMC Dev Biol 2007 21 7 11
30. Angiogenic potential of human dental pulp stromal (stem) cells. Marchionni C, Bonsi L, Alviano F, Lanzoni G, Di Tullio A, Costa R, Montanari M, Tazzari PL, Ricci F, Pasquinelli G, Orrico C, Grossi A, Prati C, Bagnara GP, Int J Immunopathol Pharmacol 2009 22 699 706 19822086
31. Biology of bone and how it orchestrates the form and function of the skeleton. Sommerfeldt DW, Rubin CT, Eur Spine J 2001 10 86 95 10.1007/s005860100283 (Pubitemid 32999811)
32. Induced endothelial cells enhance osteogenesis and vascularization of mesenchymal stem cells. Tao J, Sun Y, Wang Q, Liu C, Cells Tissues Organs 2009 190 185 193 10.1159/000218139 19420896
33. Vascular specific growth factors and blood vessel formation. Yancopoulos GD, Davis S, Gale NW, Nature 2000 407 242 248 10.1038/35025215 11001067
34. Capillary vessel network integration by inserting a vascular pedicle enhances bone formation in tissue-engineered bone using interconnected porous hydroxyapatite ceramics. Akita S, Tamai N, Myoui A, Nishikawa M, Kaito T, Takaoka K, Yoshikawa H, Tissue Eng 2004 10 789 795 10.1089/1076327041348338 15265296 (Pubitemid 38880397)
35. Engineering bone: challenges and obstacles. Logeart-Avramoglou D, Anagnostou F, Bizios R, Petite H, J Cell Mol Med 2005 9 72 84 10.1111/j.1582-4934.2005.tb00338.x 15784166
36. Vertical distraction of fibula transplant in a case of mandibular defect caused by shotgun injury. Schleier P, Hyckel P, Fried W, Beinemann J, Wurdinger J, Hinz M, Steen M, Schumann D, Int J Oral Maxillofac Surg 2006 35 861 864 10.1016/j.ijom.2006.02.010 16697147 (Pubitemid 44070645)
37. Reconstruction of large cranial defects in nonimmunosuppressed experimental design with human dental pulp stem cells. de Mendonça CA, Bueno DF, Martins MT, Kerkis I, Kerkis A, Fanganiello RD, Cerruti H, Alonso N, Passos-Bueno MR, J Craniofac Surg 2008 19 204 210 18216690 (Pubitemid 351158823)
38. Amniotic fluid-derived MSCs lead to bone differentiation when co-cultured with dental pulp stem cells. De Rosa A, Tirino V, Paino F, Tartaglione A, Mitsiadis T, Feki A, D'Aquino R, Laino L, Colacurci N, Papaccio G, Tissue Eng Part A 2011 17 645 653 10.1089/ten.tea.2010.0340 20919950
39. Scaffold design and fabrication technologies for engineering tissue state of the art and future perspectives. Hutmacher DW, J Biomater Sci 2001 12 107 124 10.1163/156856201744489 (Pubitemid 32335467)
40. In vivo bone formation by human bone marrow stromal cells: reconstruction of the mouse calvarium and mandible. Mankani MH, Kuznetsov SA, Wolfe RM, Marshall GW, Robey PG, Stem Cells 2006 24 2140 2149 10.1634/stemcells.2005-0567 16763200 (Pubitemid 44477139)
41. The effect of differentiation stage of amniotic fluid stem cells on bone regeneration. Rodrigues M, Lee BK, Lee SJ, Gomes ME, Reis RL, Atala A, Too JJ, Biomaterials 2012 33 6069 6078 10.1016/j.biomaterials.2012.05.016 22672834
42. Novel functions of the CD34 family. Nielsen JS, McNagny KM, J Cell Science 2008 121 3682 3692
43. Evaluation of endothelial cells differentiated from amniotic fluid-derived stem cells. Benavides OM, Petsche JJ, Moise KJ Jr, Johnson A, Jacot JG, Tissue Eng Part A 2012 18 1123 1131 10.1089/ten.tea.2011.0392 22250756